|
1
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012 v1.0, Estimated cancer incidence, mortality
and prevalence worldwide: IARC CancerBase No. 11
(Internet)International Agency for Research on Cancer. Lyon,
France: 2014, http://globocan.iarc.fr/pages/fact_sheets_population.aspx?country=900October
9–2014
|
|
2
|
National Cancer Institute: Breast Cancer
Treatment (PDQ®)–Patient Version. https://www.cancer.gov/types/breast/patient/breast-treatment-pdqUpdated
May 5, 2017.
|
|
3
|
Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi
H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, et
al: Mutation of the mouse klotho gene leads to a syndrome
resembling ageing. Nature. 390:45–51. 1997. View Article : Google Scholar
|
|
4
|
Matsumura Y, Aizawa H, Shiraki-Iida T,
Nagai R, Kuro-o M and Nabeshima Y: Identification of the human
Klotho gene and its two transcripts encoding membrane and secreted
Klotho protein. Biochem Biophys Res Commun. 242:626–630. 1998.
View Article : Google Scholar
|
|
5
|
Shiraki-Iida T, Aizawa H, Matsumura Y,
Sekine S, Iida A, Anazawa H, Nagai R, Kuro-o M and Nabeshima Y:
Structure of the mouse klotho gene and its two transcripts encoding
membrane and secreted protein. FEBS Lett. 424:6–10. 1998.
View Article : Google Scholar
|
|
6
|
Wolf I, Levanon-Cohen S, Bose S, Ligumsky
H, Sredni B, Kanety H, Kuro-o M, Karlan B, Kaufman B, Koeffler HP
and Rubinek T: Klotho: A tumor suppressor and a modulator of the
IGF-1 and FGF pathways in human breast cancer. Oncogene.
27:7094–7105. 2008. View Article : Google Scholar
|
|
7
|
Ito S, Kinoshita S, Shiraishi N, Nakagawa
S, Sekine S, Fujimori T and Nabeshima YI: Molecular cloning and
expression analyses of mouse betaklotho, which encodes a novel
Klotho family protein. Mech Dev. 98:115–119. 2000. View Article : Google Scholar
|
|
8
|
Ito S, Fujimori T, Furuya A, Satoh J and
Nabeshima Y and Nabeshima Y: Impaired negative feedback suppression
of bile acid synthesis in mice lacking betaKlotho. J Clin Invest.
115:2202–2208. 2005. View
Article : Google Scholar
|
|
9
|
Ogawa Y, Kurosu H, Yamamoto M, Nandi A,
Rosenblatt KP, Goetz R, Eliseenkova AV, Mohammadi M and Kuro-o M:
BetaKlotho is required for metabolic activity of fibroblast growth
factor 21. Proc Natl Acad Sci USA. 104:pp. 7432–7437. 2007,
View Article : Google Scholar
|
|
10
|
Fukumoto S: Actions and mode of actions of
FGF19 subfamily members. Endocr J. 55:23–31. 2008. View Article : Google Scholar
|
|
11
|
Tomiyama K, Maeda R, Urakawa I, Yamazaki
Y, Tanaka T, Ito S, Nabeshima Y, Tomita T, Odori S, Hosoda K, et
al: Relevant use of Klotho in FGF19 subfamily signaling system in
vivo. Proc Natl Acad Sci USA. 107:pp. 1666–1671. 2010, View Article : Google Scholar
|
|
12
|
Kurosu H, Choi M, Ogawa Y, Dickson AS,
Goetz R, Eliseenkova AV, Mohammadi M, Rosenblatt KP, Kliewer SA and
Kuro-o M: Tissue-specific expression of betaKlotho and fibroblast
growth factor (FGF) receptor isoforms determines metabolic activity
of FGF19 and FGF21. J Biol Chem. 282:26687–26695. 2007. View Article : Google Scholar
|
|
13
|
Lin BC, Wang M, Blackmore C and Desnoyers
LR: Liver-specific activities of FGF19 require Klotho beta. J Biol
Chem. 282:27277–27284. 2007. View Article : Google Scholar
|
|
14
|
Luo Y, Yang C, Lu W, Xie R, Jin C, Huang
P, Wang F and McKeehan WL: Metabolic regulator betaKlotho interacts
with fibroblast growth factor receptor 4 (FGFR4) to induce
apoptosis and inhibit tumor cell proliferation. J Biol Chem.
285:30069–30078. 2010. View Article : Google Scholar
|
|
15
|
Ye X, Guo Y, Zhang Q, Chen W, Hua X, Liu
W, Yang Y and Chen G: βKlotho suppresses tumor growth in
hepatocellular carcinoma by regulating Akt/GSK-3β/Cyclin D1
signaling pathway. PLoS One. 8:e556152013. View Article : Google Scholar
|
|
16
|
Zhu X, Zheng L, Asa SL and Ezzat S: Loss
of Heterozygosity and DNA methylation affect germline fibroblast
growth factor receptor 4 polymorphism to direct allelic selection
in breast cancer. Am J Pathol. 177:2860–2869. 2010. View Article : Google Scholar
|
|
17
|
Lakhani Sunil R: International Agency for
Research on CancerWorld Health Organization. Lyon: International
Agency for Research on Cancer; 2012
|
|
18
|
Marusyk A, Almendro V and Polyak K:
Intra-tumour heterogeneity: A looking glass for cancer? Nat Rev
Cancer. 12:323–334. 2012. View
Article : Google Scholar
|
|
19
|
Yang CY, Lu RH and Lin CH, Jen CH, Tung
CY, Yang SH, Lin JK, Jiang JK and Lin CH: Single nucleotide
polymorphisms associated with colorectal cancer susceptibility and
loss of heterozygosity in a taiwanese population. PLoS One.
9:e1000602014. View Article : Google Scholar
|
|
20
|
Chen B, Wang X, Zhao W and Wu J: Klotho
inhibits growth and promotes apoptosis in human lung cancer cell
line A549. J Exp Clin Cancer Res. 29:992010. View Article : Google Scholar
|
|
21
|
Doi S, Zou Y, Togao O, Pastor JV, John GB,
Wang L, Shiizaki K, Gotschall R, Schiavi S, Yorioka N, et al:
Klotho inhibits transforming growth factor-beta1 (TGF-beta1)
signaling and suppresses renal fibrosis and cancer metastasis in
mice. J Biol Chem. 286:8655–8665. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kotepui M, Thawornkuno C,
Chavalitshewinkoon-Petmitr P, Punyarit P and Petmitr S:
Quantitative real-time RT-PCR of ITGA7, SVEP1, TNS1, LPHN3, SEMA3G,
KLB and MMP13 mRNA expression in breast cancer. Asian Pac J Cancer
Prev. 13:5879–5882. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Poh W, Wong W, Ong H, Aung MO, Lim SG,
Chua BT and Ho HK: Klotho-beta overexpression as a novel target for
suppressing proliferation and fibroblast growth receptor-4
signaling in hepatocellular carcinoma. Mol Cancer. 11:142012.
View Article : Google Scholar : PubMed/NCBI
|
